• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.厌氧菌对N-甲酰亚胺基硫霉素(MK0787)及其他抗生素的敏感性。
Antimicrob Agents Chemother. 1982 Jun;21(6):1016-22. doi: 10.1128/AAC.21.6.1016.
2
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.一种新型稳定化硫霉素(N-甲脒基硫霉素)与其他抗生素相比的抗菌活性。
Antimicrob Agents Chemother. 1980 Jun;17(6):912-7. doi: 10.1128/AAC.17.6.912.
3
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.N-甲酰亚胺基硫霉素(MK0787):对厌氧菌的体外活性
Antimicrob Agents Chemother. 1982 Jan;21(1):168-9. doi: 10.1128/AAC.21.1.168.
4
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.硫霉素的结晶衍生物N-甲脒基硫霉素(MK0787)的体外活性
Antimicrob Agents Chemother. 1980 Oct;18(4):557-61. doi: 10.1128/AAC.18.4.557.
5
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.接种量对头孢哌酮、头孢噻肟、拉氧头孢、哌拉西林及N-甲酰亚胺硫霉素(MK0787)抗铜绿假单胞菌活性的影响。
Antimicrob Agents Chemother. 1980 Dec;18(6):893-6. doi: 10.1128/AAC.18.6.893.
6
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.新型β-内酰胺类抗生素对厌氧菌的体外活性比较
Antimicrob Agents Chemother. 1981 Nov;20(5):600-9. doi: 10.1128/AAC.20.5.600.
7
In vitro activity of N-formimidoyl thienamycin (MK0787).N-甲酰亚胺基硫霉素(MK0787)的体外活性
Antimicrob Agents Chemother. 1980 Oct;18(4):642-4. doi: 10.1128/AAC.18.4.642.
8
N-formimidoyl thienamycin (MK0787): in vitro study.N-甲酰亚胺基硫霉素(MK0787):体外研究。
Antimicrob Agents Chemother. 1981 Jan;19(1):201-4. doi: 10.1128/AAC.19.1.201.
9
A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.N-甲酰亚胺基硫霉素(MK0787)与其他近期研发的β-内酰胺衍生物抗菌活性的比较。
Antimicrob Agents Chemother. 1982 Aug;22(2):302-7. doi: 10.1128/AAC.22.2.302.
10
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.MK0787(N-亚胺甲酰硫霉素):体内外活性评估
Antimicrob Agents Chemother. 1980 Jun;17(6):993-1000. doi: 10.1128/AAC.17.6.993.

引用本文的文献

1
Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.从溃疡性结肠炎患者结肠黏膜分离出的具核梭杆菌诱导实验性溃疡性结肠炎
Gut. 2003 Jan;52(1):79-83. doi: 10.1136/gut.52.1.79.
2
Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.来自法国几家医院的厌氧菌对三种主要抗生素的敏感性
Antimicrob Agents Chemother. 1984 Jun;25(6):764-6. doi: 10.1128/AAC.25.6.764.
3
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.克拉维酸对十种β-内酰胺类药物针对脆弱拟杆菌群成员活性的影响。
Antimicrob Agents Chemother. 1984 May;25(5):662-5. doi: 10.1128/AAC.25.5.662.
4
Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.头孢匹胺与阿洛西林对厌氧菌的体外比较活性
Antimicrob Agents Chemother. 1984 Feb;25(2):162-4. doi: 10.1128/AAC.25.2.162.
5
Isolation of Clostridium pseudotetanicum from a patient with gas gangrene.从一名气性坏疽患者中分离出伪破伤风梭菌。
J Clin Microbiol. 1983 Sep;18(3):491-4. doi: 10.1128/jcm.18.3.491-494.1983.
6
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.哌拉西林。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.
7
In vitro activity of imipenem--a review.亚胺培南的体外活性——综述
Eur J Clin Microbiol. 1984 Oct;3(5):456-62. doi: 10.1007/BF02017375.
8
Cefmenoxime therapy of serious bacterial infections.头孢甲肟治疗严重细菌感染
Antimicrob Agents Chemother. 1984 Apr;25(4):510-2. doi: 10.1128/AAC.25.4.510.
9
In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.Sch 34343和头孢哌酮对厌氧菌的体外活性。
Antimicrob Agents Chemother. 1985 May;27(5):749-52. doi: 10.1128/AAC.27.5.749.
10
Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢替坦:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Nov;30(5):382-426. doi: 10.2165/00003495-198530050-00002.

本文引用的文献

1
N-formimidoyl thienamycin (MK0787): in vitro study.N-甲酰亚胺基硫霉素(MK0787):体外研究。
Antimicrob Agents Chemother. 1981 Jan;19(1):201-4. doi: 10.1128/AAC.19.1.201.
2
In vitro activity of N-formimidoyl thienamycin (MK0787).N-甲酰亚胺基硫霉素(MK0787)的体外活性
Antimicrob Agents Chemother. 1980 Oct;18(4):642-4. doi: 10.1128/AAC.18.4.642.
3
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.硫霉素的结晶衍生物N-甲脒基硫霉素(MK0787)的体外活性
Antimicrob Agents Chemother. 1980 Oct;18(4):557-61. doi: 10.1128/AAC.18.4.557.
4
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.MK0787(N-亚胺甲酰硫霉素):体内外活性评估
Antimicrob Agents Chemother. 1980 Jun;17(6):993-1000. doi: 10.1128/AAC.17.6.993.
5
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.一种新型稳定化硫霉素(N-甲脒基硫霉素)与其他抗生素相比的抗菌活性。
Antimicrob Agents Chemother. 1980 Jun;17(6):912-7. doi: 10.1128/AAC.17.6.912.
6
In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.N-甲脒基硫霉素(MK0787)对铜绿假单胞菌、表皮葡萄球菌、粘质沙雷氏菌和肠球菌属耐药菌株的体外活性
Antimicrob Agents Chemother. 1981 Jan;19(1):114-6. doi: 10.1128/AAC.19.1.114.
7
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.与头孢噻肟、拉氧头孢和头孢他啶相比,N-甲酰亚胺硫霉素的体外活性。
Antimicrob Agents Chemother. 1981 Mar;19(3):402-6. doi: 10.1128/AAC.19.3.402.

厌氧菌对N-甲酰亚胺基硫霉素(MK0787)及其他抗生素的敏感性。

Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.

作者信息

Kesado T, Watanabe K, Asahi Y, Isono M, Ueno K

出版信息

Antimicrob Agents Chemother. 1982 Jun;21(6):1016-22. doi: 10.1128/AAC.21.6.1016.

DOI:10.1128/AAC.21.6.1016
PMID:6956247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC182066/
Abstract

The susceptibilities of 462 clinical anaerobic bacterial isolates to N-formimidoyl thienamycin and 16 other currently available and investigational antibiotics were determined by the agar dilution technique. N-Formimidoyl thienamycin was significantly more active than the reference antibiotics against most organisms tested, especially Bacteroides sp., including clindamycin-resistant strains. All 462 isolates were inhibited by 4 micrograms of N-formimidoyl thienamycin per ml, and no resistant strains were found in the species tested. N-Formimidoyl thienamycin was less active (i.e., had a higher 50% minimal inhibitory concentration) against Fusobacterium sp. than clindamycin, SM-1652, and piperacillin, and less active against Clostridium difficile than metronidazole, but was equally active or more active than the other reference antibiotics tested.

摘要

采用琼脂稀释法测定了462株临床分离厌氧菌对N-甲酰亚胺硫霉素及其他16种现有和正在研究的抗生素的敏感性。N-甲酰亚胺硫霉素对大多数测试菌的活性显著高于参考抗生素,尤其是对拟杆菌属,包括对克林霉素耐药的菌株。所有462株分离菌均被每毫升4微克的N-甲酰亚胺硫霉素抑制,在所测试的菌种中未发现耐药菌株。N-甲酰亚胺硫霉素对梭杆菌属的活性低于克林霉素、SM-1652和哌拉西林(即50%最小抑菌浓度较高),对艰难梭菌的活性低于甲硝唑,但与其他测试参考抗生素活性相当或更高。